WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
LIVINGSTON, N.J., June 4 /PRNewswire/ -- Transplant surgeon, Stuart R. Geffner, M.D., Director of
Kidney and Pancreas Transplant Surgery, Saint Barnabas Health Care System Renal and Pancreas Transplant Division, is the first in the world to use the Intuitive Surgical's da Vinci(TM) Surgical System...
Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
The results of these studies will be presented during the American Transplant Congress in Boston , MA May 30 - June 3, 2009
COLUMBIA, Md., May 31 /PRNewswire/ -- The results of two large studies presented by researchers from the Starzl Transplant Institute at the University of P...
AUA Guideline: Full Kidney Removal Not Necessary for All Kidney Tumors
Early-stage renal masses should be treated with nephron-sparing approaches when possible
LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Radical nephrectomy (complete removal of the affected kidney) is not the best treatment for most small
kidney tumors because it puts patients at risk fo...
Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
- Afinitor more than doubled time without tumor growth and reduced the risk of disease progression or death by 67% compared with placebo
- Only once-daily oral cancer treatment to directly target mTOR, a protein inside the cell that controls tumor cell division and blood vessel growth
- ...
Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients
- Results to be presented at Israel Society of Nephrology Conference
- EPODURE safety and efficacy now reach 5 months from single treatment
- Data continue to indicate that Biopump may offer alternative to scores of expensive injections
MISGAV, Israel and LONDON, March 27 /PR...
DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium
Thirteen Abstracts Will Be Featured at Annual
Kidney Care Meeting
EL SEGUNDO, Calif., March 25 /PRNewswire/ -- DaVita Inc., a leading provider of
kidney care services for those diagnosed with chronic
kidney failure and disease (CKD), in conjunction with DaVita Clinical Research(R), today anno...
Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors
More Than 75 Percent of Patients Diagnosed Have Small Renal Cell Tumors; Safe Interventional Radiology Treatment Shown Near 100 Percent Effective in Destroying Localized Tumors, Says Johns Hopkins Study
SAN DIEGO, March 9 /PRNewswire-USNewswire/ -- Freezing
kidney tumors -- using a safe mi...
Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
-- EPODURE Biopump demonstrates safety and efficacy for four months with
single administration
-- Institutional Review Board confirms safety and efficacy of low dose and
approves continuation of trial with higher doses
-- Biopump may offer alternative to months of expensive i...
Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
- New data, updated since ASCO, show time without tumor growth now reaches nearly 5 months with RAD001 vs. 1.9 months with placebo
- One quarter of patients in trial remained progression-free beyond ten months of treatment
- RAD001 is first drug to show significa...
VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
Van Andel Institute researchers are first to associate unique DNA changes with several types of renal cell carcinoma
GRAND RAPIDS, Mich., Sept. 12 /PRNewswire/ -- Van Andel Institute (VAI)
researchers have identified unique DNA changes in each of several types of
renal cell carcin...
RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
-- Regulatory applications to be submitted worldwide for RAD001 first submissions filed in the Hidden List US, EU and Switzerland
-- Data showing that RAD001 more than doubles time without tumor growth and reduced risk of disease progression by 70% now published in The...
Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success
Study Highlights Performance of Abbott's ARCHITECT Tacrolimus Assay, Only
Automated Transplant Monitoring Test that Meets International Standards for Low-Level Monitoring
WASHINGTON, July 30 /PRNewswire-FirstCall/ -- The ability of blood
tests to precisely measure very ...
DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
EL SEGUNDO, Calif., June 23 /PRNewswire/ -- DaVita Inc., a leading
provider of
kidney care services for those diagnosed with chronic kidney
failure and disease (CKD), recently introduced its EMPOWER program, a
series of free community-based workshops that encourage CKD patients to
take control...
CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI
TORONTO, June 4 /PRNewswire/ -- The 12-month results from a multicenter
trial monitoring CellCept(R) (mycophenolate mofetil) in combination with
calcineurin inhibitors (CNIs) in renal transplantation was presented today
at the American Transplant Congress (ATC). The study results showed that a...
University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
New data presented at annual American Transplant Congress in Toronto
MIAMI, June 2 /PRNewswire/ -- Manuel R. Carreno, MD, and colleagues in
the Departments of Surgery and Pathology at the University of Miami -
Lawrence Miller School of Medicine have corroborated the value of
monitoring cell-...
New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
- Data Showed Overall Survival Benefit With TORISEL Regardless of
Nephrectomy Status; Additional Analysis Examined Specific Side Effects -
COLLEGEVILLE, Pa., May 31 /PRNewswire-FirstCall/ -- Wyeth
Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced results
of two new analy...
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
COLLEGEVILLE, Pa., May 30 /PRNewswire-FirstCall/ -- Wyeth
Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced the
initiation of the INTORACT (INvestigation of TORISEL and Avastin
Combination Therapy) study, a worldwide randomized, open-label, phase 3b
study comparing TORISEL(R)...
Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon
- Tolerability is an Increasingly Important Factor When Selecting Treatment Options for Patients - ABSTRACT No: 5110 (Poster 6H)
BASEL, Switzerland, May 30 /PRNewswire/ -- Data presented at the
largest oncology meeting in the world, the American Societ...
RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
- RECORD-1 trial shows RAD001 reduces risk of disease progression by 70%
- RAD001 is first and only drug to show significant benefit after failure
of approved therapies Sutent(R) or Nexavar(R),** with potential to address unmet medical need
- Once-daily oral RAD001 di...
Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
DALLAS, April 4, 2008 /PRNewswire/ -- Data from five studies sponsored
by Ortho Biotech Products, L.P. will be presented at the National Kidney
Foundation (NKF) 2008 Spring Clinical Meetings from April 2 - 6, 2008;
three utilization studies involve PROCRIT(R) (Epoetin alfa).
The data include...
Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
'On Track' Initiative Provides Broader Access to FOSRENOL(R) and Resources for Enhanced Hyperphosphatemia Management
PHILADELPHIA, April 3, 2008 /PRNewswire/ -- Shire Pharmaceuticals, the
global biopharmaceutical company, today announced the launch of On Track,
an innovative progr...
St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable
Surgeons were able to save part of each
kidney in patients with
bilateral Wilms tumor, regardless of how the tumors appear on preoperative
scans
MEMPHIS, Tenn., March 24 /PRNewswire-USNewswire/ -- St. Jude Children's
Research Hospital physicians have demonstrated that children with bilater...
Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
- Outstanding interim results cause independent data monitoring committee
to immediately share findings; patients on placebo to be offered everolimus - Everolimus (RAD001) tablet, taken once daily, demonstrated highly
effective anti-tumor activity through continuous targeted inhibition of ...
Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
PHILADELPHIA, Jan. 14 /PRNewswire/ -- Kibow Biotech, Inc. is pleased to
announce that it has been granted an International Patent Cooperation
Treaty (PCT) patent from Australia, China and India. The approved patent,
"Prebiotic and Probiotic Compositions and their Method of use for Gut-based
Th...
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Study Shows that Long-Term Soliris Therapy Continued to Be Associated with
Reductions in Thrombosis and Improvements in Fatigue, Quality of Life, and Anemia in PNH Patients
Data Presented at the American Society of Hematology (ASH) Annual Meeting Po...
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
TORISEL Extends Median Overall Survival vs. Interferon-Alpha
COLLEGEVILLE, Pa., Nov. 26 /PRNewswire-FirstCall/ -- Wyeth
Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced today that the
European Commission has approved TORISEL(TM) (temsirolimus) for the
first-line treatment of...
Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
MADISON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- The majority of people
with diabetes and/or high blood pressure -- the two leading causes of
chronic
kidney disease (CKD) -- are not receiving recommended tests to
identify this disease early, when medical treatment can slow or halt
disease progr...
Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
September 11, 2007
WASHINGTON, Sept. 12 /PRNewswire-USNewswire/ -- The following is a
statement by KCP Chairman Dr. Edward Jones: Yesterday's FDA Advisory Committee meeting underscores the many
considerations that must be factored in to policymaking related to anemi...
UCLA Program Aims to Revolutionize Kidney Transplants
LOS ANGELES, Aug. 10 /PRNewswire-USNewswire/ -- New and innovative
programs to obtain donor organs have the potential to revolutionize kidney
transplantation. At UCLA, for example, transplant experts are studying a
program they call "living donor swap." This program enables the relative or fr...
Advanced Magnetics Announces Presentation of Ferumoxytol Data at
the National Kidney Foundation 2007 Spring Clinical Meetings
CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --
Advanced Magnetics today announced that data from three completed
Phase III multi- center clinical studies of ferumoxytol as an
intravenous iron replacement therapeutic will be presented during
the National
Kidney Foundation (NKF) 2007 Spr...
Nearly 1 in 10 Americans Has A Relative With Kidney Failure
African-Americans with Family History of ESRD Are at High
Risk
WASHINGTON, March 9, 2007 - Approximately ten percent of U.S.
adults have a family history of end-stage renal disease (ESRD), and
these individuals appear to be at increased risk of developing
kidney disease themselves, reports a ...
Isotechnika's independent data monitoring committee conducts review
of phase 2b kidney transplant trial
- Company Set to Host Evening Symposium at ATC -
EDMONTON, March 27 /CNW/ - Isotechnika Inc. announced today that
an independent data monitoring committee (DMC) has met and reviewed
the interim data from the Phase 2b
kidney transplant (PROMISE)
trial. The review included 3 month data from ...
Data Analyses Outline Efficacy and Safety of Mircera for the
Treatment of Renal Anemia Associated With Chronic Kidney Disease
ORLANDO, Fla. and NUTLEY, N.J., April 12, 2007
/PRNewswire-FirstCall/ -- Data analyses from the largest initial
registration clinical trial program ever undertaken in the renal
anemia arena provide efficacy and safety information on the
investigational anemia therapy MIRCERA(TM) for the treatment ...
Genzyme Announces Successful Completion of Study Investigating
Sevelamer Carbonate in Patients With Chronic Kidney Disease
CAMBRIDGE, Mass., April 16, 2007 /PRNewswire-FirstCall/ --
Genzyme Corp. announced today that a recently completed study of
Renvela(TM) (sevelamer carbonate) achieved its primary endpoint,
demonstrating a statistically significant reduction in serum
phosphorus for hyperphosphatemic patients with c...
Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month
Hematide for the Treatment of Anemia in Patients with Early- and
End-Stage Chronic Kidney Disease
PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - Affymax, Inc.
(Nasdaq:AFFY) today announced results to date from two separate
Phase 2 clinical trials of Hematide(TM) in dialysis and
non-dialysis chronic
kidney disease (CKD) patients. The data showed
that in treatment naive, non-dialysis patients...
Mircera Effective in Stabilising Haemoglobin Levels in Elderly
Patients With Kidney Disease on Dialysis
Findings Illustrate Role of Innovative New Treatment in Population
Most Affected by Chronic
Kidney Disease
BASEL, Switzerland, April 23, 2007 /PRNewswire/ -- A new Roche
Phase III analysis shows once-monthly MIRCERA, a continuous
erythropoietin receptor activator, effectively treats renal anaemia
...
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
...plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to adva...
Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
...insulin through a pump. Insulin, however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications which may include
kidney failure, blindness, heart disease, stroke, and amputation.
Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has aw...
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
... plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to adva...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
... plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to adva...